Patent · US Active

Combination therapy using immunoglobulin and C1-Inhibitor

US10471142B2 · kind B2 · utility

4Cited by

6References

17Claims

0Family size

Assignees

CSL Behring AG · DE
THE GOVERNMENT OF THE UNITED STATES OF AMERICA · US

Inventors

Milan Basta · Rockville, US
Xinzhi Chen · Kunshan, CN
Mark Mattson · Bel Air, US

Key dates

Filing date	Sep 21, 2012
Grant date	Nov 12, 2019
Priority date	—
Expiry date	Nov 2, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are disclosed for treating cerebral ischemia using a combination of C1-INH and immunoglobulin, such as human plasma derived immunoglobulin (IVIG).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.